InvestorsHub Logo
Followers 225
Posts 8698
Boards Moderated 0
Alias Born 03/21/2001

Re: None

Thursday, 03/31/2022 4:21:13 PM

Thursday, March 31, 2022 4:21:13 PM

Post# of 647226
ACRX Interesting 8-k just out. They released news on a study but not the info in the 8-k. The 8-k is the news they should have released.

Item 8.01 Other Events

As previously disclosed, on February 11, 2021, AcelRx Pharmaceuticals, Inc. (the “Company”) received a warning letter from the Office of Prescription Drug Promotion (“OPDP”) of the U.S. Food and Drug Administration (the “FDA”) (the “Warning Letter”) relating to certain promotional materials used by the Company in 2019.

On March 28, 2022, the Company received a Warning Letter close-out letter (“close-out letter”) from the OPDP indicating that the FDA has concluded its evaluation of the Company’s corrective actions in response to the Warning Letter and that the Company has addressed the issues raised by the Warning Letter.

https://www.sec.gov/Archives/edgar/data/0001427925/000143774922007847/acrx20220331_8k.htm

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.